<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05627349</url>
  </required_header>
  <id_info>
    <org_study_id>CMUH111-REC2-065</org_study_id>
    <nct_id>NCT05627349</nct_id>
  </id_info>
  <brief_title>The Evaluation for Fu's Subcutaneous Needling (FSN) in Carpal Tunnel Syndrome.</brief_title>
  <official_title>The Evaluation for Fu's Subcutaneous Needling in Carpal Tunnel Syndrome: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to evaluate the efficacy of Fu's Subcutaneous Needling&#xD;
      (FSN) in carpal tunnel syndrome (CTS). The main questions it aims to answer are:&#xD;
&#xD;
        -  Dose FSN improve the symptoms of CTS?&#xD;
&#xD;
        -  Dose FSN decrease cross section area of median nerve in CTS patients?&#xD;
&#xD;
        -  Dose FSN have the effect of electrophysiology exam in CTS patients? Participants will&#xD;
           receive wrist splinting and FSN treatment respectively. Researchers will compare wrist&#xD;
           splinting group with FSN group to see if FSN being effective for CTS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 20, 2023</start_date>
  <completion_date type="Anticipated">June 20, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Boston Carpal Tunnel Questionnaire (BCTQ)</measure>
    <time_frame>Change from baseline at one month after treatment.</time_frame>
    <description>BCTQ</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of electrophysiology exam</measure>
    <time_frame>Change from baseline at one month after treatment.</time_frame>
    <description>Exam of motor latency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of cross section area of median nerve in ultrasound</measure>
    <time_frame>Change from baseline at one month after treatment</time_frame>
    <description>cross section area of median nerve</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>wrist splinting group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wrist splinting at night for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FSN group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The needle inserted at the midpoint of the anterior forearm of the affected side. Swaying movement (SM) frequency is 200 times in 2 minutes. Reperfusion approach (RA) was performed with slow repetitively grasping movement while SM. On the 1st, 2nd, and 4th days, three times of FSN treatment were arranged.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>wrist splinting</intervention_name>
    <description>standard wrist splinting at night for 2 weeks</description>
    <arm_group_label>wrist splinting group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FSN</intervention_name>
    <description>FSN is a single-use disposable needle(Trocar Acupuncture Needle, Nanjing FSN Medical Co. , Ltd, China.). The needle body is solid, and covered with a plastic tube. The needle penetrates the skin with insertion device. Under the guidance of ultrasound, the needle enter the loose subcutaneous layer obliquely without penetrating into the muscle. This is the difference from traditional acupuncture. The insertion point is midpoint of the anterior forearm. The needle tip is toward the carpal tunnel. After the needle is inserted, SM and RA are performed. The frequency of SM is 200 times in two minutes. The method of SM is to make a horizontal fan swaying with the base of the needle as the fulcrum. RA is performed while SM-slowly make a fist for 10 seconds and then relax for 5 seconds. Eight times of RA in two minutes. After the FNS treatment, the needle was withdrawn.</description>
    <arm_group_label>FSN group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female aged 20-85 years old.&#xD;
&#xD;
          2. Meet the diagnosis of mild to moderate carpal tunnel syndrome.&#xD;
&#xD;
          3. If the patient has carpal tunnel syndrome in both hands, choose the side with mild or&#xD;
             moderate carpal tunnel syndrome.&#xD;
&#xD;
          4. After being explained, join the trial voluntarily and sign the subject's consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Caused by trauma or mass lesion.&#xD;
&#xD;
          2. Thenar muscle atrophy.&#xD;
&#xD;
          3. Electrophysiological examination revealed severe CTS.&#xD;
&#xD;
          4. Chronic kidney disease, rheumatoid arthritis, abnormal thyroid function, diabetes.&#xD;
&#xD;
          5. Psychiatric history or incapable of cooperating with the investigator.&#xD;
&#xD;
          6. Pregnancy.&#xD;
&#xD;
          7. History of substance abuse or long-term steroid use.&#xD;
&#xD;
          8. History of median nerve surgery.&#xD;
&#xD;
          9. Those who do not sign the consent form.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chih Ying Wu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>China Medical University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chih Ying Wu, MD</last_name>
    <phone>+886 4 2205 2121</phone>
    <phone_ext>5094</phone_ext>
    <email>zingwu1029@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>China Medical University Hsinchu Hospital</name>
      <address>
        <city>Zhubei</city>
        <state>Hsinchu County</state>
        <zip>302</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Chih-Ying Wu, MD</last_name>
      <phone>+886 4 2205 2121</phone>
      <phone_ext>5094</phone_ext>
      <email>zingwu1029@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chih Ying Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 15, 2022</study_first_submitted>
  <study_first_submitted_qc>November 23, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2022</study_first_posted>
  <last_update_submitted>February 7, 2023</last_update_submitted>
  <last_update_submitted_qc>February 7, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fu's Subcutaneous Needling, carpal tunnel syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

